Cargando…

The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations

An effective analytical method is requisite to ensure the accurate identification and quantification of drug(s), either in bulk material or in complex matrices, which form part of finished pharmaceutical products. For the purpose of a pharmaceutical formulation study, it became necessary to have a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Omoteso, Omobolanle Ayoyinka, Milne, Marnus, Aucamp, Marique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837449/
https://www.ncbi.nlm.nih.gov/pubmed/35154325
http://dx.doi.org/10.1155/2022/3510277
_version_ 1784649911218733056
author Omoteso, Omobolanle Ayoyinka
Milne, Marnus
Aucamp, Marique
author_facet Omoteso, Omobolanle Ayoyinka
Milne, Marnus
Aucamp, Marique
author_sort Omoteso, Omobolanle Ayoyinka
collection PubMed
description An effective analytical method is requisite to ensure the accurate identification and quantification of drug(s), either in bulk material or in complex matrices, which form part of finished pharmaceutical products. For the purpose of a pharmaceutical formulation study, it became necessary to have a simple, yet robust and reproducible reversed-phase HPLC method for the simultaneous detection and quantification of lamivudine (3TC), tenofovir disoproxil fumarate (TDF), and dolutegravir sodium (DTG) in bulk form, complex polymeric matrices, and during drug release studies. A suitable method was developed using a Kinetex® C(18), 250 × 4.6 mm column as stationary phase and a mobile phase consisting of 50 : 50 v/v methanol and water with 1 mL orthophosphoric acid, with a flow rate of 1.0 mL/min and column temperature maintained at 35°C. A detection wavelength of 260 nm and an injection volume of 10 μL were used. The method was validated according to the International Conference on Harmonization (ICH) guideline Q2 (R(1)), and the parameters of linearity and range, accuracy, precision, specificity, limit of detection (LOD), limit of quantification (LOQ), robustness, and stability were all determined. Acceptable correlation coefficients for linearity (R(2)) of >0.998 for each of the three drugs were obtained. The LOD was quantified to be 56.31 μg/mL, 40.27 μg/mL, and 7.00 μg/mL for 3TC, TDF, and DTG, respectively, and the LOQ was quantified as 187.69 μg/mL, 134.22 μg/mL, and 22.5 μg/mL for 3TC, TDF, and DTG, respectively. In relation to all the determined validation parameters, this method proves to be suitable for the accurate identification and quantification of the three ARVs, either alone or in combination, as well as when incorporated into polymeric matrices. Furthermore, the method proves to be suitable to detect degradation of the compounds.
format Online
Article
Text
id pubmed-8837449
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88374492022-02-12 The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations Omoteso, Omobolanle Ayoyinka Milne, Marnus Aucamp, Marique Int J Anal Chem Research Article An effective analytical method is requisite to ensure the accurate identification and quantification of drug(s), either in bulk material or in complex matrices, which form part of finished pharmaceutical products. For the purpose of a pharmaceutical formulation study, it became necessary to have a simple, yet robust and reproducible reversed-phase HPLC method for the simultaneous detection and quantification of lamivudine (3TC), tenofovir disoproxil fumarate (TDF), and dolutegravir sodium (DTG) in bulk form, complex polymeric matrices, and during drug release studies. A suitable method was developed using a Kinetex® C(18), 250 × 4.6 mm column as stationary phase and a mobile phase consisting of 50 : 50 v/v methanol and water with 1 mL orthophosphoric acid, with a flow rate of 1.0 mL/min and column temperature maintained at 35°C. A detection wavelength of 260 nm and an injection volume of 10 μL were used. The method was validated according to the International Conference on Harmonization (ICH) guideline Q2 (R(1)), and the parameters of linearity and range, accuracy, precision, specificity, limit of detection (LOD), limit of quantification (LOQ), robustness, and stability were all determined. Acceptable correlation coefficients for linearity (R(2)) of >0.998 for each of the three drugs were obtained. The LOD was quantified to be 56.31 μg/mL, 40.27 μg/mL, and 7.00 μg/mL for 3TC, TDF, and DTG, respectively, and the LOQ was quantified as 187.69 μg/mL, 134.22 μg/mL, and 22.5 μg/mL for 3TC, TDF, and DTG, respectively. In relation to all the determined validation parameters, this method proves to be suitable for the accurate identification and quantification of the three ARVs, either alone or in combination, as well as when incorporated into polymeric matrices. Furthermore, the method proves to be suitable to detect degradation of the compounds. Hindawi 2022-02-04 /pmc/articles/PMC8837449/ /pubmed/35154325 http://dx.doi.org/10.1155/2022/3510277 Text en Copyright © 2022 Omobolanle Ayoyinka Omoteso et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Omoteso, Omobolanle Ayoyinka
Milne, Marnus
Aucamp, Marique
The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title_full The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title_fullStr The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title_full_unstemmed The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title_short The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
title_sort validation of a simple, robust, stability-indicating rp-hplc method for the simultaneous detection of lamivudine, tenofovir disoproxil fumarate, and dolutegravir sodium in bulk material and pharmaceutical formulations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837449/
https://www.ncbi.nlm.nih.gov/pubmed/35154325
http://dx.doi.org/10.1155/2022/3510277
work_keys_str_mv AT omotesoomobolanleayoyinka thevalidationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations
AT milnemarnus thevalidationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations
AT aucampmarique thevalidationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations
AT omotesoomobolanleayoyinka validationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations
AT milnemarnus validationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations
AT aucampmarique validationofasimplerobuststabilityindicatingrphplcmethodforthesimultaneousdetectionoflamivudinetenofovirdisoproxilfumarateanddolutegravirsodiuminbulkmaterialandpharmaceuticalformulations